These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37568072)

  • 1. Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content.
    De Robertis R; Spoto F; Autelitano D; Guagenti D; Olivieri A; Zanutto P; Incarbone G; D'Onofrio M
    Radiol Med; 2023 Oct; 128(10):1174-1180. PubMed ID: 37568072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing ultrasound-derived fat fraction and MRI-PDFF for quantifying hepatic steatosis: a real-world prospective study.
    Qi R; Lu L; He T; Zhang L; Lin Y; Bao L
    Eur Radiol; 2024 Oct; ():. PubMed ID: 39414658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-Derived Fat Fraction for Hepatic Steatosis Assessment: Prospective Study of Agreement With MRI PDFF and Sources of Variability in a Heterogeneous Population.
    Kubale R; Schneider G; Lessenich CPN; Buecker A; Wassenberg S; Torres G; Gurung A; Hall T; Labyed Y
    AJR Am J Roentgenol; 2024 Jun; 222(6):e2330775. PubMed ID: 38506537
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison With MRI Proton Density Fat Fraction as Reference Standard.
    Dillman JR; Thapaliya S; Tkach JA; Trout AT
    AJR Am J Roentgenol; 2022 Nov; 219(5):784-791. PubMed ID: 35674351
    [No Abstract]   [Full Text] [Related]  

  • 5. Real-time ultrasound-derived fat fraction in pediatric population: feasibility validation with MR-PDFF.
    Zalcman M; Barth RA; Rubesova E
    Pediatr Radiol; 2023 Nov; 53(12):2466-2475. PubMed ID: 37667050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Method for Ultrasound-Derived Fat Fraction Using an Integrated Phantom.
    Labyed Y; Milkowski A
    J Ultrasound Med; 2020 Dec; 39(12):2427-2438. PubMed ID: 32525261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Three Ultrasound-Based Techniques for Diagnosing and Grading Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Wang P; Song D; Han J; Zhang J; Chen H; Gao R; Shen H; Li J
    Acad Radiol; 2024 Sep; ():. PubMed ID: 39294051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
    Tran BV; Ujita K; Taketomi-Takahashi A; Hirasawa H; Suto T; Tsushima Y
    PLoS One; 2021; 16(8):e0255768. PubMed ID: 34383812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of ultrasound-derived fat fraction for the detection and quantification of hepatic steatosis in patients with liver biopsy.
    Nakamura Y; Hirooka M; Koizumi Y; Yano R; Imai Y; Watanabe T; Yoshida O; Tokumoto Y; Abe M; Hiasa Y
    J Med Ultrason (2001); 2024 Jun; ():. PubMed ID: 38918301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis using ultrasound-derived fat fraction: First technical and clinical evaluation.
    Huang YL; Cheng J; Wang Y; Xu XL; Wang SW; Wei L; Dong Y
    Clin Hemorheol Microcirc; 2024; 86(1-2):51-61. PubMed ID: 37638422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of ultrasound hepatorenal index for the diagnosis of hepatic steatosis in children.
    Frankland MP; Dillman JR; Anton CG; Coley BD; Nasser MP; O'Hara SM; Li Y; Trout AT
    Pediatr Radiol; 2022 Jun; 52(7):1306-1313. PubMed ID: 35229183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-estimated hepatorenal index: diagnostic performance and interobserver agreement for pediatric liver fat quantification.
    Hajibonabi F; Riedesel EL; Taylor SD; Linam LE; Alazraki AL; Zhang C; Khanna G
    Pediatr Radiol; 2024 Sep; 54(10):1653-1660. PubMed ID: 39136769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction.
    Satapathy SK; Gonzalez HC; Vanatta J; Dyer A; Angel W; Nouer SS; Kocak M; Kedia SK; Jiang Y; Clark I; Yadak N; Nezakagtoo N; Helmick R; Horton P; Campos L; Agbim U; Maliakkal B; Maluf D; Nair S; Halford HH; Eason JD
    PLoS One; 2020; 15(5):e0232006. PubMed ID: 32407331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study.
    Hirooka M; Ogawa S; Koizumi Y; Yoshida Y; Goto T; Yasuda S; Yamahira M; Tamai T; Kuromatsu R; Matsuzaki T; Suehiro T; Kamada Y; Sumida Y; Hiasa Y; Toyoda H; Kumada T
    J Gastroenterol; 2024 Jun; 59(6):504-514. PubMed ID: 38553657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard.
    Caussy C; Brissot J; Singh S; Bassirian S; Hernandez C; Bettencourt R; Rizo E; Richards L; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1842-1850.e6. PubMed ID: 31843596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
    Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
    Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI-PDFF as the reference standard.
    Mu R; Xia YC; Zhu KY; Lu JY; Luo Q; Zhang L; Lin RK; Cai XB; Qu Y; Lu LG
    J Dig Dis; 2023 Dec; 24(12):691-701. PubMed ID: 37994615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK; Lee JM; Joo I; Park SJ
    Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.